There are structural differences in neutral sugar moieties between sixteen-and fourteen-membered macrolide antibiotics.
Although 14-membered macrolides possess mainly either cladinose or mycarose at the C-3 position, Fig. 1 . Sixteen-membered macrolide antibiotics possessing unsubstituted L-mycaroseas a neutral sugar. APR. 1997 only mycarose is attached to the C-4' position in 16-memberedmacrolides. Since a sixteen-membered macrolide having an unsubstituted a-L-cladinosyl residue has not been reported, studies of the compounds4-6 would be challenging. accompanied with recovered 1 (16%). Useful cleavage of the 3-0-acyl group in leucomycin family by synthetic chemistry has not been reported. Next, these 4-O-acyl-L-cladinose derivatives (1 -3) were converted to the corresponding unsubstituted lcladinose analogues (4-6) respectively, using Mucor spinescens IAM 607113) or Paecilomyces sp. PF11089).
All new compoundsprovided satisfactory spectroscopic data (Table 1) . One explanation concerning these incomplete conversion yields might involve steric hindrance of a 3//-<9-methyl group of 1~3. Bioconversion of a 4-0-acyl-L-mycarose derivative to the unsubstituted-Lmycarose analogue was proceeded more efficiently13).
This difficulty about 4//-de-O-propionylation by biological medium of 1 -3 might suggest that a 4"-<9-acyl group of these cladionose analogues would be hardly cleaved by metabolism in vivo in comparison with that of the L-mycarose counterparts. Antibacterial activities in vitro of the novel unsubstituted a-L-cladinosyl derivatives (4 -6) , compared with those of sixteen-memberedmacrolide antibiotics possessing L-mycarose, 4"-de-O-propionylmidecamycin A1 13) (7), DOP14) and leucomycin V15) (LM-V) ( Fig. 1 ), are shown in Table 2 . As judged from MIC values, these cladinose analogues exhibited about four to sixteen times higher activity than their counterparts respectively (for example 4 vs. 7). This is the first report about 16-membered macrolides having unsubstituted cladinose at the C-4' position, since it has been difficult to predict enhancement of in vitro activity by introducing a methyl group into the 3"-OH.
A neutral sugar moiety of natural sixteen-membered macrolide antibiotics and their acylated derivatives is converted to unsubstituted mycarose by metabolism in general. As reported partly in our previous paper7), however, compound 1 and its 9-O-acetyl derivative (8) were mainly metabolized to an active metabolite 4 in mice. Actually, compound 4 was detected as a main metabolite in urine after oral administration of8 in mice.
Moreover, incubation of 8 with human liver S9 fraction gave 4 as one of major metabolites. These observations explained that the 4-0-acyl-L-cladinose analogues, compound 1, 3 and their derivatives, for example 8, could exhibit dramatically improved efficacy in vivo (In leucomycin family, compounds having an sp3 carbon at the C-9 position exhibited superior efficacy in vivo4>16) than those having an sp2 carbon like compound 2).
In conclusion, a series of sixteen-membered macrolides possessing an unsubstituted a-L-cladinose moiety were prepared via appropriate biotransformations. They showed antibacterial activity four to sixteen-fold more potent in vitro than the counterparts with the a-Lmycarose moiety. The clarified preliminary metabolic pathway of 1 and 3 and the described potency of their metabolites (4 and 6) open the way for eventually new metabolically-programmed sixteen-membered macrolide antibiotics.
